• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 8/9/24: AI Companies Fight to Stop California Safety Rules, Building Patient-centric Technology & more

News
Article

The latest news for pharma industry insiders.

Building Patient-centric Technology

In part 2 of this video interview, Vincent Keunen, founder & CEO of Andaman7 highlights how technology vendors should be keeping the patient in mind when building solutions.

Payers to Increase Utilization Management if the IRA Leads to Higher Costs

In a recent survey, payers said their priorities include addressing the impacts of Medicare’s Drug Price Negotiation Program and the Part D redesign.

AI Companies Fight to Stop California Safety Rules

Industry says a bill moving through the state legislature would chill innovation for the young technology.

New Global Healthy Living Foundation Survey Highlights Barriers to Vaccine Access for High-Risk Chronic Disease Adults

The Global Healthy Living Foundation (GHLF) has released a new report titled “Challenges to Vaccine Access for High-Risk Chronic Disease Adults,” which uncovers vaccine access challenges faced by adults with chronic diseases. Despite zero out-of-pocket costs for eligible vaccines, many adults face substantial barriers due to restrictive policies and a lack of clarity in immunization policies.

Charlotte Owens, MD, FACOG on LinkedIn

Far too many women in the U.S. experience complications during childbirth.

Many of these deaths are preventable or treatable with the appropriate tools and protocols in place, avoiding potentially devastating social and economic effects.

As an OB/GYN, I’ve supported many patients throughout their birth journeys, which should be a joyous experience for mothers and their babies. I’ve also seen the negative impact that birth complications can have women and their families, which fuels my passion further to invest in and expand maternal care services for women everywhere.

I recently had the chance to speak with Miranda Schmalfuhs for Pharmaceutical Executive about how Organon alongside the medical community, is working to ensure these outstanding needs in maternal care are addressed and that quality maternal care is available to all women.

#MaternalHealth #ClosingtheGap

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs